Cochlear completes recruitment for global pivotal trial of fully implantable hearing system

• Cochlear completed recruitment for its global pivotal trials of fully implantable hearing technology, moving the program toward regulatory submissions.
• Patient use across the research program exceeded 1 million hours; pivotal studies include 92 patients with follow-up and data collection ongoing.
• More than 100 people have been implanted across the full research program, including feasibility studies dating back to 2005.
• Development priorities focus on all-day performance with battery longevity, internal dual-microphone design, familiar surgery, long-term clinical evidence.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cochlear Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609281401BIZWIRE_USPR_____20260928_BW955470) on September 28, 2026, and is solely responsible for the information contained therein.